Company: BLTE
Filing Date: 2025-12-02
Form Type: 6-K
Source: 0001104659-25-117690
Chunk: 1

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 6-K
Chunk 1
---
 to and qualified in their entirety by reference to the Underwriting Agreement, which is attached hereto
as Exhibit 1.1, and is incorporated herein by reference.

The legal opinions of Maples and Calder (Hong
Kong) LLP relating to the ADSs are filed as Exhibits 5.1 to this Form 6-K and incorporated by reference herein.

The consent of Marcum Asia CPAs LLP is filed
as Exhibit 23.3 to this Form 6-K and incorporated by reference herein.

On December 1, 2025, the Company issued
a press release announcing the pricing of the Offering. A copy of this press release is filed as Exhibit 99.1 to this Form 6-K.

The information contained in this Form 6-K,
including Exhibits 1.1, 5.1 and 23.3 hereto, but excluding Exhibit 99.1, is hereby incorporated by reference into the Company’s
Registration Statement on Form F-3 (File No. 333-284521).

| Exhibit No. 
 1.1         |     | Description of Exhibit                                                        
 Underwriting Agreement, dated December 1, 2025                                |
|:------------|:----|:------------------------------------------------------------------------------|
| 5.1         |     | Opinion of Maples and Calder (Hong Kong) LLP                                  |
| 23.1        |     | Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit 5.1 hereto) |
| 23.3        |     | Consent of Marcum Asia CPAs LLP                                               |
| 99.1        |     | Press Release dated December 1, 2025                                          |

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Belite Bio, Inc |                                      |
| By:             | /s/ Yu-Hsin Lin                      |
| Name:           | Yu-Hsin Lin                          |
| Title:          | Chief Executive Officer and Chairman |

Date: December 2, 2025